These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 24492665)
41. Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury. He H; Liu L; Chen Q; Liu A; Cai S; Yang Y; Lu X; Qiu H Cell Transplant; 2015; 24(9):1699-715. PubMed ID: 25291359 [TBL] [Abstract][Full Text] [Related]
42. Emerging roles of mechanosensitive ion channels in acute lung injury/acute respiratory distress syndrome. Jia Q; Yang Y; Chen X; Yao S; Hu Z Respir Res; 2022 Dec; 23(1):366. PubMed ID: 36539808 [TBL] [Abstract][Full Text] [Related]
43. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review. Sadeghi B; Ringdén O; Gustafsson B; Castegren M Front Immunol; 2022; 13():963445. PubMed ID: 36426365 [TBL] [Abstract][Full Text] [Related]
44. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine? Xu F; Hu Y; Zhou J; Wang X J Cell Mol Med; 2013 Aug; 17(8):927-35. PubMed ID: 23834470 [TBL] [Abstract][Full Text] [Related]
45. Advances in mesenchymal stromal cell therapy for acute lung injury/acute respiratory distress syndrome. Liu C; Xiao K; Xie L Front Cell Dev Biol; 2022; 10():951764. PubMed ID: 36036014 [TBL] [Abstract][Full Text] [Related]
46. [Research progress of mesenchymal stem cells in the treatment of ALI]. Zhou H; Liu M; Lyu X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):1039-1042. PubMed ID: 29151424 [TBL] [Abstract][Full Text] [Related]
47. Alveolar Fluid Clearance in Pathologically Relevant Conditions: Huppert LA; Matthay MA Front Immunol; 2017; 8():371. PubMed ID: 28439268 [TBL] [Abstract][Full Text] [Related]
48. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats. Zhao Y; Yang C; Wang H; Li H; Du J; Gu W; Jiang J Int Immunopharmacol; 2013 Feb; 15(2):246-53. PubMed ID: 23273653 [TBL] [Abstract][Full Text] [Related]
49. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828 [TBL] [Abstract][Full Text] [Related]
50. Mesenchymal Stem Cells Reconditioned in Their Own Serum Exhibit Augmented Therapeutic Properties in the Setting of Acute Respiratory Distress Syndrome. Xu AL; Rodriguez LA; Walker KP; Mohammadipoor A; Kamucheka RM; Cancio LC; Batchinsky AI; Antebi B Stem Cells Transl Med; 2019 Oct; 8(10):1092-1106. PubMed ID: 31219247 [TBL] [Abstract][Full Text] [Related]